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ABSTRACT   
Lower respiratory infections are among the leading causes of death worldwide. In this study, it was evaluated the 
interaction of indocyanine green, a photosensitizer activated by infrared light, with alveolar macrophages and the 
effectiveness of the photodynamic therapy using this compound against Streptococcus pneumoniae . Initial experiments 
analyzed indocyanine green toxicity to alveolar macrophages in the dark with different drug concentrations and 
incubation times, and macrophage viability was obtained with the MTT method. The average of the results showed 
viability values below 90% for the two highest concentrations. Experiments with Streptococcus pneumoniae showed 
photodynamic inactivation with 10 µM indocyanine green solution. Further experiments with the bacteria in co-culture 
with AM will be conducted verifying the photodynamic inactivation effectiveness of the tested drug concentrations and 
incubation periods using infrared light. 
  
Keywords: Photodynamic inactivation, infrared light, pulmonary diseases, alveolar macrophages.  
 
*ilaiali.leite@usp.br; phone +55 16 33739810 (218); cepof.ifsc.usp.br 
 
1. INTRODUCTION  
 
Although noncommunicable diseases were responsible for two-thirds of all deaths in 2011, lower respiratory infections 
are among the leading causes of mortality worldwide, being responsible for 3.2 million deaths (figure 1)1. One of these 
infections, pneumonia, is the leading cause of death in children, being most prevalent in South Asia and sub-Saharan 
Africa and responsible for 18% of all deaths of children under 5 years old2. It can be caused by bacteria, viruses or fungi 
and affects the lungs, filling the alveoli with fluids and pus. This process limits the oxygen intake, promotes cough and 
makes breathing painful. Transmission may occur via air-borne droplets from cough or sneeze, but one may become 
infected by inhaling viruses of bacteria commonly found in the mouth, nose or throat (common contamination 
mechanism of patients receiving continuous mechanical ventilation). 
 
Mild cases of pneumonia can be treated at home with repose, fever control and the ingestion of plenty of fluids. Some of 
these cases and more severe ones are usually treated with antibiotics (even if it’s caused by virus, almost one third of the 
cases of community-acquired pneumonia involve bacterial-viral co-infection3, requiring both antiviral and antibacterial 
medication). However, the growing microbial resistance to these drugs has been reducing their effectiveness, creating a 
necessity of developing new approaches. 
 
Photodynamic therapy (PDT) is a technique based on the interaction of light with a photoactive substance, called 
photosensitizer (PS), to promote cellular death. It was first reported in 1900 by a medical student, Oscar Raab, 
Endoscopic Microscopy IX; and Optical Techniques in Pulmonary Medicine, edited by Guillermo J. Tearney, 
Thomas D. Wang, Melissa J. Suter, Stephen Lam, Matthew Brenner, Proc. of SPIE Vol. 8927, 89271A  
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conducting a research with Infusoria and acridine red4. The first large series of patients submitted to PDT was reported in 
1978, where primary and secondary skin tumors were successfully treated5.  Since then, a variety of studies have been 
reported using PDT to treat several types of tumors and other diseases, including pathologies of microbial, viral, fungal 
and inflammatory origins6. In an oxygen-rich environment, cellular components are oxidized by reactive oxygen-species 
(ROS) produced when PSs are activated by a specific incident wavelength. Because of the PS preferential absorption by 
abnormal tissue or the infectious agent and the short lifespan of ROS, PDT has a local action and produces selective 
damage7. Due its oxidation character, PDT prevents the development of resistance by its target, representing an 
interesting alternative for conventional treatment of bacterial infections. 
 
 
Figure 1. The leading causes of death in the world by percentage1.  
 
In order to perform PDT, some parameters must be previously defined: the PS to be applied, its concentration and its 
incubation time, and an adequate light source and its power, capable of both reach the therapeutic target and activate de 
PS. The 600-1200 nm interval within the electromagnetic spectrum is called optical window, where both light absorption 
and scattering are lower for the principal human tissue chromophores, melanin and hemoglobin, therefore allowing better 
tissue penetration of light (higher wavelength display deeper penetration)8. 
 
Indocyanine green (ICG) is a tricarbocyanine dye with an absorption peak between 700-810 nm9. It’s an amphiphilic 
molecule of 774.96 Da formed by two polycyclic structures with sulfonic groups negatively charged at one end, 
connected by a carbon chain10,11. It has been used for diagnosis, due its fluorescence, since 1956 for ophthalmologic 
angiography, plasma volume determination, cardiac output measurements, object localization in tissues and hepatic 
function studies12,13. With low incidence of collateral effects, ICG was FDA approved in 1959 and several studies show 
its efficacy in PDT for acne vulgaris treatment, occlusion of choroidal neovascularization, eradication of wound 
inhabiting microorganisms, melanoma cells, colonic cancer cells, breast cancer cells and oral squamous carcinoma 
cells14,15,16,17,18,19,20. 
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In this study, it was evaluated the interaction of ICG, a PS activated at infrared region of the electromagnetic spectrum, 
with an important immune effector cell, the alveolar macrophage (AM). These primary phagocytes are located in the 
pulmonary alveolus and display a major role in both the defense of the organism against respiratory pathogens and in the 
immunologic chain21,22. The effectiveness of PDT against one of the most common bacteria responsible for pneumonia 
was also analyzed, aiming to determine an effective and safe protocol, as proof of concept, for the application of ICG-
PDT for Streptococcus pneumonia inactivation. 
 
2. METHODOLOGY 
 
Initial experiments aimed to determine ICG (figure 2) cytotoxicity to AM in the dark. The cells were obtained from Rio 
de Janeiro’s Cell Bank. 96-well plates were previously prepared containing in each well 105 cells in Dulbecco's Modified 
Eagle's Medium (DMEM) supplemented with 5% fetal bovine serum and placed overnight in an incubator (5% CO2, 37 
ºC). Two experimental parameters were evaluated: drug concentration and incubation time. Due to the lack of similar 
research with this substance for PDT, a wide range of concentrations (9.37, 18.75, 37.5, 75, 150 and 300 µM) and three 
incubation times (10, 20 and 30 minutes) were selected. Macrophages viability was indirectly determined via the MTT 
assay (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide), a colorimetric method based on the conversion of 
MTT (yellow) into formazan crystals (blue) by living cells. To quantify the conversion, each well’s optical density was 
measured at 570 nm wavelength. The experiments were repeated using 2.5% of bovine fetal serum. 
 
Figure 2. Indocyanine green’s chemical structure. 
 
Photodynamic inactivation effectiveness against Streptococcus pneumoniae was evaluated with an 850 nm Biotable® 
(figure 3), equipment with radiation intensity of 30 mW/cm2 containing several light emitting diodes. At a standard  
concentration of 107 bacterias, the samples were diluted in phosphate buffered saline (PBS) for 10, 20 and 30 minutes in 
a 96-well plates, and were irradiated with a light dose of  30 J/cm2 (for ICG concentrations of 10 and 50 µM) and 10 
J/cm2. (for ICG concentrations of 0.1, 1 and 10 µM). In both cases, mirror plates were prepared under the same 
conditions, but were not irradiated with any light (controls). 
 
Figure 3. Biotable® - 850 nm, 30 mW/cm2. 
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3. RESULTS 
 
Cytotoxicity experiments with the 5% bovine fetal serum complemented medium displayed peculiar results. Viability 
values oscillated with the concentration increase for 10 minutes incubation (figure 4I): the lowest value, 83.3%, was 
yielded by the 9.37 µM ICG, followed by a 93% displayed by 18.75 µM and 89.5% of 37.5 µM. The higher value is 
95.5% held by the 75 µM concentration. 20 minutes incubation time results start with a 95.4% of AM viability, being 
reduced with the increase of the PS concentration, except for the 18.75 µM, that exhibited a slight increase when 
compared to the 9.37 µM result, and the 150 µM viability, the higher value for this group (figure 4II). Another 
oscillation, more pronounced, is observed in the 30 minutes of incubation, but the lowest viability values belong to the 
higher concentrations (figure 4III). 
 
Figure 4. Graphic of alveolar macrophage viability with 5 % fetal bovine serum supplemented medium after indocyanine 
green incubation for: I) 10 minutes, II) 20 minutes and III) 30 minutes. 
 
To diminish the cellular growth overnight, the fetal bovine serum concentration was reduced to 2.5%. The three lower 
ICG concentrations almost didn’t affect the AM when it was incubated for 10 minutes, with viability values around 98% 
except for 75 and 150 µM that yielded values of 92.9 % and 91%, respectively (figure 5I). With 20 minutes of 
incubation, there was observed a decrease in almost all viability rates, except for the lowest concentration and the 75µM, 
displaying an increase of 1.8% and 6.5%. The two highest concentrations had a greater impact on the cells, with viability 
percentage around 86 (figure 5II).  For 30 minutes on incubation, all viability values display a reduction when compared 
with the obtained in 10 and 20 minutes of incubation (figure 5III). Also, observing the values of the different 
concentrations, the viability values are reduced almost gradually as the PS concentration increases. 
 
Figure 5. Graphic of alveolar macrophage viability with 2.5 % fetal bovine serum supplemented medium after indocyanine 
green incubation for: I) 10 minutes, II) 20 minutes and III) 30 minutes. 
 
The first experiments with the 850 nm Biotable® (with a light dose of 30 J/cm2) showed ICG toxic effects: control groups 
with 50 µM and 10 µM contained 500 and 12500 colonies forming unit per milliliter (UFC/mL), a reduction of 4 and 3 
log10, respectively (figure 6). Light alone displayed a bactericidal effect at physiological temperatures, with a 5 log10 
UFC/mL decrease, and photodynamic inactivation presented complete bacteria eradication. 
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Figure 6. Results of Streptococcus pneumoniae photodynamic inactivation with indocyanine green, irradiated with infrared 
light (850 nm, 30 J/cm2 light dose). 
 
In order to reduce the damage promoted by the light and the PS, both light dose and ICG concentration were modified: 
the new parameters were 10, 1 and 0.1 µM and 10 J/cm2. The results showed lower impact on the control group, with 1 
log10 reduction of UFC/mL for the higher ICG concentration (figure 7). PDT had almost no effect against S. pneumoniae 
when 0.1 and 1 µM solutions were applied, but 10 µM displayed bactericidal effects, reducing the UFC/mL in almost 6 
log10.  
 
Figure 7. Results of Streptococcus pneumoniae photodynamic inactivation with indocyanine green, irradiated with infrared 
light (850 nm, 10 J/cm2 light dose). 
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4. CONCLUSION 
 
Indocyanine green’s cytotoxicity results revealed an overall lower viability rates for 150 and 300 µM. In order to 
minimize alveolar macrophages damage, the posterior experiments were conducted excluding these concentrations. 
Initial PDT with an 850 nm Biotable® tests were performed with 10 and 50 µM ICG solutions and also displayed the 
compound’s toxicity and light damaging effects against Streptococcus pneumoniae, suggesting that lower photosensitizer 
concentration and irradiation time would produce better results. This was confirmed using 10, 1 and 0.1 µM solutions 
and applying a 10 J/cm2 light dose, and only the higher concentration promoted photodynamic inactivation. Further 
experiments aiming to verify the localization of indocyanine green in alveolar macrophages and bacteria cultures will be 
performed. The photodynamic inactivation of S. pneumoniae in a co-culture with the macrophages will also be studied, 
to determine if the photodynamic therapy assists the immunological mechanism to fight the infection.   
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